Emergence of antibiotic resistance-associated clones among Escherichia coli recovered from newborns with early-onset sepsis and meningitis in the United States, 2008-2009

Journal of the Pediatric Infectious Diseases Society

Volumn 5, Issue 3, 2016, Pages 269-276

  Weissman, Scott J ^a   Hansen, Nellie I ^b   Zaterka Baxter, Kristen ^b   Higgins, Rosemary D ^c   Stoll, Barbara J ^d,e,f  

^a SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b RTI INTERNATIONAL   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^f Eunice Kennedy Shriver National Institute   (United States)

Author keywords

Antibiotic resistance; Early onset sepsis; Escherichia coli; ST131

Indexed keywords

BETA LACTAMASE; GENTAMICIN; MEMBRANE ANTIGEN; MEROPENEM; AMINOGLYCOSIDE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CHILD; ESCHERICHIA COLI; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; HUMAN; INFANT; MENINGITIS; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEPSIS; UNITED STATES; AMPICILLIN RESISTANCE; BACTERIAL MENINGITIS; BACTERIUM IDENTIFICATION; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; NEWBORN; NEWBORN SEPSIS; PATHOGENICITY; PHYLOGENY; VIRULENCE;

AMINOGLYCOSIDES; AMPICILLIN RESISTANCE; BACTERIAL TYPING TECHNIQUES; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FLUOROQUINOLONES; HUMANS; INFANT, NEWBORN; MENINGITIS, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MULTILOCUS SEQUENCE TYPING; NEONATAL SEPSIS; PHYLOGENY; PLASMIDS; UNITED STATES; VIRULENCE;

EID: 84995612380     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/piv013     Document Type: Article

References (39)

1. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: "the other bad E coli". J Lab Clin Med 2002; 139:155-62.
2. AchtmanM, Mercer A, Kusecek B, et al. Six widespread bacterial clones among Escherichia coli K1 isolates. Infect Immun 1983; 39:315-35.
3. Pitout JD. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012; 3:9.
4. Shakir SM, Goldbeck JM, Robison D, et al. Genotypic and phenotypic characterization of invasive neonatal Escherichia coli clinical isolates. Am J Perinatol 2014; 31:975-82.
5. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E coli disease continues. Pediatrics 2011; 127:817-26.
6. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66:4555-8.
7. Wirth T, Falush D, Lan R, et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol 2006; 60: 1136-51.
8. Weissman SJ, Johnson JR, Tchesnokova V, et al. High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol 2012; 78:1353-60.
9. Johnson JR, Murray AC, Gajewski A, et al. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob Agents Chemother 2003; 47:2161-8.
10. Qin X, Zerr DM, Weissman SJ, et al. Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children's hospital experience. Antimicrob Agents Chemother 2008; 52:3909-14.
11. Barroso H, Freitas-Vieira A, Lito LM, et al. Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases at a Portuguese hospital: TEM-10 as the endemic enzyme. J Antimicrob Chemother 2000; 45:611-6.
12. Batchelor M, Hopkins K, Threlfall EJ, et al. bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003. Antimicrob Agents Chemother 2005; 49:1319-22.
13. Clermont O, Johnson JR, Menard M, Denamur E. Determination of Escherichia coli O types by allele-specific polymerase chain reaction: application to the O types involved in human septicemia. Diagn Microbiol Infect Dis 2007; 57:129-36.
14. Weissman SJ, Chattopadhyay S, Aprikian P, et al. Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli. Mol Microbiol 2006; 59:975-88.
15. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-72.
16. Johnson TJ, Wannemuehler YM, Johnson SJ, et al. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol 2007; 73:1976-83.
17. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010; 65: 2518-29.
18. Schiffer MS, Oliveira E, Glode MP, et al. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Pediatr Res 1976; 10:82-7.
19. Boyd EF, Hill CW, Rich SM, Hartl DL. Mosaic structure of plasmids from natural populations of Escherichia coli. Genetics 1996; 143:1091-100.
20. Mercer AA, Morelli G, Heuzenroeder M, et al. Conservation of plasmids among Escherichia coli K1 isolates of diverse origins. Infect Immun 1984; 46:649-57.
21. Vejborg RM, Friis C, Hancock V, et al. A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics 2010; 283:469-84.
22. Johnson JR, Tchesnokova V, Johnston B, et al. Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli. J Infect Dis 2013; 207:919-28.
23. Weissman SJ, Adler A, Qin X, Zerr DM. Emergence of extendedspectrum beta-lactam resistance among Escherichia coli at a US academic children's hospital is clonal at the sequence type level for CTX-M-15, but not for CMY-2. Int J Antimicrob Agents 2013; 41:414-20.
24. Woodford N, Carattoli A, Karisik E, et al. Complete nucleotide sequences of plasmids pEK204, pEK499 and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25: H4-ST131 clone. Antimicrob Agents Chemother 2009; 4472-82.
25. Riley LW. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin Microbiol Infect 2014; 20:380-90.
26. Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J 2011; 30:937-41.
27. Tchesnokova V, Billig M, Chattopadhyay S, et al. Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcome. J Clin Microbiol 2013; 51:2991-9.
28. Heffron F, Sublett R, Hedges RW, et al. Origin of the TEM-beta-lactamase gene found on plasmids. J Bacteriol 1975; 122:250-6.
29. Manges AR, Johnson JR, Foxman B, et al. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345:1007-13.
30. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25: H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008; 61:273-81.
31. Banerjee R, Johnson JR. A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131. Antimicrob Agents Chemother 2014; 58:4997-5004.
32. Price LB, Johnson JR, Aziz M, et al. The epidemic of extended-spectrum-beta-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. MBio 2013; 4:e00377-13.
33. Burdet C, Clermont O, Bonacorsi S, et al. Escherichia coli bacteremia in children: age and portal of entry are the main predictors of severity. Pediatr Infect Dis J 2014; 33:872-9.
34. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001; 183:78-88.
35. McCracken GH Jr, Sarff LD, Glode MP, et al. Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet 1974; 2: 246-50.
36. Robbins JB, McCracken GH Jr, Gotschlich EC, et al. Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med 1974; 290:1216-20.
37. Johnson JR, Oswald E, O'Bryan TT, et al. Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis 2002; 185:774-84.
38. Johnson JR, O'Bryan TT, Delavari P, et al. Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. J Infect Dis 2001; 183:1508-17.
39. Johnson JR, Delavari P, O'Bryan TT. Escherichia coli O18:K1: H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. J Infect Dis 2001; 183:425-34.